Literature DB >> 18178721

Ischemia-induced activation of AMPK does not increase glucose uptake in glycogen-replete isolated working rat hearts.

Mohamed A Omar1, Heather Fraser, Alexander S Clanachan.   

Abstract

Alterations in myocardial glucose metabolism are a key determinant of ischemia-induced depression of left ventricular mechanical function. Since myocardial glycogen is an important source of endogenous glucose, we compared the effects of ischemia on glucose uptake and utilization in isolated working rat hearts in which glycogen content was either replete (G replete, 114 micromol/g dry wt) or partially depleted (G depleted, 71 mumol/g dry wt). The effects of low-flow ischemia (LFI, 0.5 ml/min) on glucose uptake, glycogen turnover (glycogenolysis and glycogen synthesis), glycolysis, adenosine 5'-monophosphate-activated protein kinase (AMPK) activity, and GLUT4 translocation were measured. Relative to preischemic values, LFI caused a time-dependent reduction in glycogen content in both G-replete and G-depleted groups due to an acceleration of glycogenolysis (by 12-fold and 6-fold, respectively). In G-replete hearts, LFI (15 min) decreased glucose uptake (by 59%) and did not affect GLUT4 translocation. In G-depleted hearts, LFI also decreased initially glucose uptake (by 90%) and glycogen synthesis, but after 15 min, when glycogenolysis slowed due to exhaustion of glycogen content, glucose uptake increased (by 31%) in association with an increase in GLUT4 translocation. After 60 min of LFI, glucose uptake, glycogenolysis, and glycolysis recovered to near-preischemic values in both groups. LFI increased AMPK activity in a time-dependent manner in both groups (by 6-fold and 4-fold, respectively). Thus, when glycogen stores are replete before ischemia, ischemia-induced AMPK activation is not sufficient to increase glucose uptake. Under these conditions, an acceleration of glycogen degradation provides sufficient endogenous substrate for glycolysis during ischemia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18178721     DOI: 10.1152/ajpheart.01087.2007

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  4 in total

1.  Metformin prevents ischaemic ventricular fibrillation in metabolically normal pigs.

Authors:  Li Lu; Shuyu Ye; Rebecca L Scalzo; Jane E B Reusch; Clifford R Greyson; Gregory G Schwartz
Journal:  Diabetologia       Date:  2017-05-11       Impact factor: 10.122

2.  Anti-hypoxic effect of ginsenoside Rbl on neonatal rat cardiomyocytes is mediated through the specific activation of glucose transporter-4 ex vivo.

Authors:  Hong-liang Kong; Jian-ping Wang; Zhan-quan Li; Shu-mei Zhao; Jing Dong; Wei-wei Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-03-23       Impact factor: 6.150

3.  Hypoxia decreases creatine uptake in cardiomyocytes, while creatine supplementation enhances HIF activation.

Authors:  Lucia Santacruz; Antonio Jose Luis Arciniegas; Marcus Darrabie; Jose G Mantilla; Rebecca M Baron; Dawn E Bowles; Rajashree Mishra; Danny O Jacobs
Journal:  Physiol Rep       Date:  2017-08

Review 4.  Dissecting the role of AMP-activated protein kinase in human diseases.

Authors:  Jin Li; Liping Zhong; Fengzhong Wang; Haibo Zhu
Journal:  Acta Pharm Sin B       Date:  2017-03-03       Impact factor: 11.413

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.